Smith, Moore & Co’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-112,892
Closed -$2.84M – 539
2025
Q3
$2.84M Buy
112,892
+2,481
+2% +$62.4K 0.22% 93
2025
Q2
$2.78M Buy
110,411
+4,636
+4% +$116K 0.23% 91
2025
Q1
$2.66M Buy
105,775
+455
+0.4% +$11.4K 0.25% 90
2024
Q4
$2.64M Buy
105,320
+16,250
+18% +$407K 0.24% 91
2024
Q3
$2.24M Buy
89,070
+1,925
+2% +$48K 0.21% 94
2024
Q2
$2.17M Buy
87,145
+11,232
+15% +$278K 0.22% 93
2024
Q1
$1.88M Buy
75,913
+46,512
+158% +$1.15M 0.2% 104
2023
Q4
$728K Buy
+29,401
New +$720K 0.09% 198

Other funds holding IBDQ

Smith, Moore & Co's IBDQ Position: Q4 2025 in Review

Smith, Moore & Co sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 112,892 shares — an estimated $2.84M sold.

Smith, Moore & Co first reported a position in IBDQ in Q4 2023 and held it in 8 quarters. The position peaked at $2.84M in Q3 2025. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • Smith, Moore & Co reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Smith, Moore & Co sold 112,892 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $2.84M.
  • Smith, Moore & Co first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q4 2023 and held it in 8 quarters.
  • Smith, Moore & Co's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $2.84M in Q3 2025.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Smith, Moore & Co's 13F filing for Q4 2025, filed 23 Jan 2026.